Zydus Life

Zydus Life shares drop nearly 3% as UBS maintains ‘Sell’ rating

Zydus Life stock jumps 4% as Nomura upgrades to ‘Buy’ with Rs 1,140 target

UBS initiates Sell call on Zydus, Dr Reddy’s, Aurobindo Pharma, Lupin

UBS has initiated sell ratings on key Indian pharmaceutical stocks including Zydus, Dr. Reddy's, Aurobindo, and Lupin, citing overestimated core margins and slow growth in their primary markets of India and the US.

BofA Securities cuts target prices for Zydus Life and Lupin shares amid Mirabegron uncertainty

Stocks to watch today: Adani Power, Samvardhana Motherson, Zydus announce key deals; Vedanta CEO resigns

Jefferies upgrades Zydus Life to Buy, expects stock to rally 30%

Global brokerage firm Jefferies has upgraded Zydus Life to a "Buy" rating, raising its target price to Rs 1,450. This target price for Zydus Life shares implies a 30% upside from the current market price of Rs 1,113 on the NSE.

Zydus Life shares surge 6% on strong Q3 earnings, buyback announcement

Zydus Life’s board has approved a buyback of Rs 600 crore or 57.9 lakh shares at Rs 1,005 along with its Q3 earnings.

Stocks To Watch Today: Vedanta, Zydus Life, Jindal Stainless, NBCC, GR Infra

Top stocks to watch are Vedanta, Zydus Life, Jindal Stainless, NBCC, GR Infra, besides others.